These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24125885)

  • 1. Targeting the hydrophobic region of Hsp90's ATP binding pocket with novel 1,3,5-triazines.
    Lee T; Seo YH
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6427-31. PubMed ID: 24125885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
    Jeong JH; Oh YJ; Lho Y; Park SY; Liu KH; Ha E; Seo YH
    Eur J Med Chem; 2016 Nov; 124():1069-1080. PubMed ID: 27783977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.
    Miura T; Fukami TA; Hasegawa K; Ono N; Suda A; Shindo H; Yoon DO; Kim SJ; Na YJ; Aoki Y; Shimma N; Tsukuda T; Shiratori Y
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5778-83. PubMed ID: 21875802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel subunits of the mammalian Hsp90 signal transduction chaperone.
    Te J; Jia L; Rogers J; Miller A; Hartson SD
    J Proteome Res; 2007 May; 6(5):1963-73. PubMed ID: 17348703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp90 structure and function studied by NMR spectroscopy.
    Didenko T; Duarte AM; Karagöz GE; Rüdiger SG
    Biochim Biophys Acta; 2012 Mar; 1823(3):636-47. PubMed ID: 22155720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the Hsp90 system.
    Sima S; Richter K
    Biochim Biophys Acta Mol Cell Res; 2018 Jun; 1865(6):889-897. PubMed ID: 29563055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and mechanism of the Hsp90 molecular chaperone machinery.
    Pearl LH; Prodromou C
    Annu Rev Biochem; 2006; 75():271-94. PubMed ID: 16756493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP Impedes the Inhibitory Effect of Hsp90 on Aβ
    Wang H; Lallemang M; Hermann B; Wallin C; Loch R; Blanc A; Balzer BN; Hugel T; Luo J
    J Mol Biol; 2021 Jan; 433(2):166717. PubMed ID: 33220262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'active life' of Hsp90 complexes.
    Prodromou C
    Biochim Biophys Acta; 2012 Mar; 1823(3):614-23. PubMed ID: 21840346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the dynamic chaperoning of disordered clients by Hsp90.
    Qu X; Zhao S; Wan C; Zhu L; Ji T; Rossi P; Wang J; Kalodimos CG; Wang C; Xu W; Huang C
    Nat Struct Mol Biol; 2024 Oct; 31(10):1482-1491. PubMed ID: 38890550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and optimization of a useful assay for determining Hsp90's inherent ATPase activity.
    Avila C; Kornilayev BA; Blagg BS
    Bioorg Med Chem; 2006 Feb; 14(4):1134-42. PubMed ID: 16213144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 inhibition with resorcyclic acid lactones (RALs).
    Winssinger N; Fontaine JG; Barluenga S
    Curr Top Med Chem; 2009; 9(15):1419-35. PubMed ID: 19860733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reinventing Hsp90 Inhibitors: Blocking C-Terminal Binding Events to Hsp90 by Using Dimerized Inhibitors.
    Koay YC; Wahyudi H; McAlpine SR
    Chemistry; 2016 Dec; 22(51):18572-18582. PubMed ID: 27859703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of pyrimidinyl acyl thioureas as novel Hsp90 inhibitors in invasive ductal breast cancer and its bone metastasis.
    Koca İ; Özgür A; Er M; Gümüş M; Açikalin Coşkun K; Tutar Y
    Eur J Med Chem; 2016 Oct; 122():280-290. PubMed ID: 27376491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone.
    Vallée F; Carrez C; Pilorge F; Dupuy A; Parent A; Bertin L; Thompson F; Ferrari P; Fassy F; Lamberton A; Thomas A; Arrebola R; Guerif S; Rohaut A; Certal V; Ruxer JM; Gouyon T; Delorme C; Jouanen A; Dumas J; Grépin C; Combeau C; Goulaouic H; Dereu N; Mikol V; Mailliet P; Minoux H
    J Med Chem; 2011 Oct; 54(20):7206-19. PubMed ID: 21972823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90: breaking the symmetry.
    Mayer MP; Le Breton L
    Mol Cell; 2015 Apr; 58(1):8-20. PubMed ID: 25839432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.
    Gavenonis J; Jonas NE; Kritzer JA
    Bioorg Med Chem; 2014 Aug; 22(15):3989-93. PubMed ID: 24984936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure insights into mechanisms of ATP hydrolysis and the activation of human heat-shock protein 90.
    Li J; Sun L; Xu C; Yu F; Zhou H; Zhao Y; Zhang J; Cai J; Mao C; Tang L; Xu Y; He J
    Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):300-6. PubMed ID: 22318716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.
    Brandt GE; Blagg BS
    Curr Top Med Chem; 2009; 9(15):1447-61. PubMed ID: 19860731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal domain of human Hsp90 triggers binding to the cochaperone p23.
    Karagöz GE; Duarte AM; Ippel H; Uetrecht C; Sinnige T; van Rosmalen M; Hausmann J; Heck AJ; Boelens R; Rüdiger SG
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):580-5. PubMed ID: 21183720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.